<?xml version='1.0' encoding='utf-8'?>
<document id="22312373"><sentence text="The influence of high-dose simvastatin and diltiazem on myocardium in rabbits: a haemodynamic study."><entity charOffset="27-38" id="DDI-PubMed.22312373.s1.e0" text="simvastatin" /><entity charOffset="43-52" id="DDI-PubMed.22312373.s1.e1" text="diltiazem" /><pair ddi="false" e1="DDI-PubMed.22312373.s1.e0" e2="DDI-PubMed.22312373.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22312373.s1.e0" e2="DDI-PubMed.22312373.s1.e1" /></sentence><sentence text="Simvastatin and diltiazem are often prescribed together for the treatment of hypercholesterolaemia in patients with hypertension and/or angina pectoris"><entity charOffset="0-11" id="DDI-PubMed.22312373.s2.e0" text="Simvastatin" /></sentence><sentence text=" However, diltiazem, a CYP3A inhibitor, is a well-recognized risk factor of skeletal muscle myopathy" /><sentence text=" It is not known whether such interaction also affects myocardial efficiency causing haemodynamic changes" /><sentence text=" The aim of the experiment was to establish the impact of simvastatin co-administered with diltiazem on the haemodynamic parameters after continuous infusion of dopamine"><entity charOffset="58-69" id="DDI-PubMed.22312373.s5.e0" text="simvastatin" /><entity charOffset="91-100" id="DDI-PubMed.22312373.s5.e1" text="diltiazem" /><entity charOffset="161-169" id="DDI-PubMed.22312373.s5.e2" text="dopamine" /><pair ddi="false" e1="DDI-PubMed.22312373.s5.e0" e2="DDI-PubMed.22312373.s5.e0" /><pair ddi="false" e1="DDI-PubMed.22312373.s5.e0" e2="DDI-PubMed.22312373.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22312373.s5.e0" e2="DDI-PubMed.22312373.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22312373.s5.e1" e2="DDI-PubMed.22312373.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22312373.s5.e1" e2="DDI-PubMed.22312373.s5.e2" /></sentence><sentence text="" /><sentence text="The experiments were performed on 28 New Zealand white rabbits" /><sentence text=" The animals were divided into four groups receiving: 0" /><sentence text="2% MC - methylcellulose (control group); diltiazem; simvastatin; simvastatin + diltiazem, for 14 days (po)"><entity charOffset="52-63" id="DDI-PubMed.22312373.s9.e0" text="simvastatin" /></sentence><sentence text=" The following haemodynamic parameters were estimated: cardiac output index (CI), heart rate (HR), systolic blood pressure (SBP), mean blood pressure (MBP), diastolic blood pressure (DBP) and total peripheral resistance index (TPRI)" /><sentence text=" The registration of haemodynamic parameters was performed by the Doppler method and during the experiments the animals were anaesthetized with α-chloralose (75 mg/kg bw) and urethane (500 mg/kg bw)"><entity charOffset="144-156" id="DDI-PubMed.22312373.s11.e0" text="α-chloralose" /><entity charOffset="175-183" id="DDI-PubMed.22312373.s11.e1" text="urethane" /><pair ddi="false" e1="DDI-PubMed.22312373.s11.e0" e2="DDI-PubMed.22312373.s11.e0" /><pair ddi="false" e1="DDI-PubMed.22312373.s11.e0" e2="DDI-PubMed.22312373.s11.e1" /></sentence><sentence text="" /><sentence text="Dopamine did not cause a statistically significant increase in CI in rabbits receiving simvastatin alone"><entity charOffset="0-8" id="DDI-PubMed.22312373.s13.e0" text="Dopamine" /><entity charOffset="87-98" id="DDI-PubMed.22312373.s13.e1" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.22312373.s13.e0" e2="DDI-PubMed.22312373.s13.e0" /><pair ddi="false" e1="DDI-PubMed.22312373.s13.e0" e2="DDI-PubMed.22312373.s13.e1" /></sentence><sentence text=" Diltiazem significantly increased CI if given simultaneously with simvastatin, which might suggest the improvement of cardiac efficiency resulting from such interaction"><entity charOffset="67-78" id="DDI-PubMed.22312373.s14.e0" text="simvastatin" /></sentence><sentence text="" /><sentence text="The possibility of another mechanism of drug-drug interaction than the one based on CYP3A inhibition, and its impact on cardiac or skeletal muscle, might be considered" /><sentence text="" /></document>